Selected research
Industry Growth & Trends
Global Apatinib Industry Growth and Trends Forecast to 2032
Market perspective
The global Apatinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Apatinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Apatinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Apatinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Apatinib include Jiangsu Hengrui Medicine, LSK BioPartners, Bukwang Pharmaceutical Company and Advenchen Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Apatinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Apatinib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Apatinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Apatinib.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Apatinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Apatinib Market by Company
Jiangsu Hengrui Medicine
LSK BioPartners
Bukwang Pharmaceutical Company
Advenchen Laboratories
Apatinib Segment by Type
0.25g/Pcs
0.425g/Pcs
0.375g/Pcs
Apatinib Segment by Application
Advanced Hepatocellular Carcinoma
Metastatic Breast Cancer
Metastatic Gastric Carcinoma
Others
Apatinib Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apatinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apatinib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apatinib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apatinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Apatinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g/Pcs
- 0.425g/Pcs
- 0.375g/Pcs
Applications
- Advanced Hepatocellular Carcinoma
- Metastatic Breast Cancer
- Metastatic Gastric Carcinoma
- Others
Companies covered
- Jiangsu Hengrui Medicine
- LSK BioPartners
- Bukwang Pharmaceutical Company
- Advenchen Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Apatinib Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Apatinib Sales Estimates and Forecasts (2021-2032)
- 1.3 Apatinib Market by Type
- 1.3.1 0.25g/Pcs
- 1.3.2 0.425g/Pcs
- 1.3.3 0.375g/Pcs
- 1.4 Global Apatinib Market Size by Type
- 1.4.1 Global Apatinib Market Size Overview by Type (2021-2032)
- 1.4.2 Global Apatinib Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Apatinib Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Apatinib Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Apatinib Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Apatinib Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Apatinib Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Apatinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Apatinib Industry Trends
- 2.2 Apatinib Industry Drivers
- 2.3 Apatinib Industry Opportunities and Challenges
- 2.4 Apatinib Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Apatinib Revenue (2021-2026)
- 3.2 Global Top Players by Apatinib Sales (2021-2026)
- 3.3 Global Top Players by Apatinib Price (2021-2026)
- 3.4 Global Apatinib Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Apatinib Major Company Production Sites & Headquarters
- 3.6 Global Apatinib Company, Product Type & Application
- 3.7 Global Apatinib Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Apatinib Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Apatinib Players Market Share by Revenue in 2025
- 3.8.3 2025 Apatinib Tier 1, Tier 2, and Tier 3
4 Apatinib Regional Status and Outlook
- 4.1 Global Apatinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Apatinib Historic Market Size by Region
- 4.2.1 Global Apatinib Sales in Volume by Region (2021-2026)
- 4.2.2 Global Apatinib Sales in Value by Region (2021-2026)
- 4.2.3 Global Apatinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Apatinib Forecasted Market Size by Region
- 4.3.1 Global Apatinib Sales in Volume by Region (2027-2032)
- 4.3.2 Global Apatinib Sales in Value by Region (2027-2032)
- 4.3.3 Global Apatinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Apatinib by Application
- 5.1 Apatinib Market by Application
- 5.1.1 Advanced Hepatocellular Carcinoma
- 5.1.2 Metastatic Breast Cancer
- 5.1.3 Metastatic Gastric Carcinoma
- 5.1.4 Others
- 5.2 Global Apatinib Market Size by Application
- 5.2.1 Global Apatinib Market Size Overview by Application (2021-2032)
- 5.2.2 Global Apatinib Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Apatinib Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Apatinib Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Apatinib Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Apatinib Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Apatinib Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Apatinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Jiangsu Hengrui Medicine
- 6.1.1 Jiangsu Hengrui Medicine Company Information
- 6.1.2 Jiangsu Hengrui Medicine Business Overview
- 6.1.3 Jiangsu Hengrui Medicine Apatinib Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Jiangsu Hengrui Medicine Apatinib Product Portfolio
- 6.1.5 Jiangsu Hengrui Medicine Recent Developments
- 6.2 LSK BioPartners
- 6.2.1 LSK BioPartners Company Information
- 6.2.2 LSK BioPartners Business Overview
- 6.2.3 LSK BioPartners Apatinib Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 LSK BioPartners Apatinib Product Portfolio
- 6.2.5 LSK BioPartners Recent Developments
- 6.3 Bukwang Pharmaceutical Company
- 6.3.1 Bukwang Pharmaceutical Company Company Information
- 6.3.2 Bukwang Pharmaceutical Company Business Overview
- 6.3.3 Bukwang Pharmaceutical Company Apatinib Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bukwang Pharmaceutical Company Apatinib Product Portfolio
- 6.3.5 Bukwang Pharmaceutical Company Recent Developments
- 6.4 Advenchen Laboratories
- 6.4.1 Advenchen Laboratories Company Information
- 6.4.2 Advenchen Laboratories Business Overview
- 6.4.3 Advenchen Laboratories Apatinib Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Advenchen Laboratories Apatinib Product Portfolio
- 6.4.5 Advenchen Laboratories Recent Developments
7 North America by Country
- 7.1 North America Apatinib Sales by Country
- 7.1.1 North America Apatinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Apatinib Sales by Country (2021-2026)
- 7.1.3 North America Apatinib Sales Forecast by Country (2027-2032)
- 7.2 North America Apatinib Market Size by Country
- 7.2.1 North America Apatinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Apatinib Market Size by Country (2021-2026)
- 7.2.3 North America Apatinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Apatinib Sales by Country
- 8.1.1 Europe Apatinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Apatinib Sales by Country (2021-2026)
- 8.1.3 Europe Apatinib Sales Forecast by Country (2027-2032)
- 8.2 Europe Apatinib Market Size by Country
- 8.2.1 Europe Apatinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Apatinib Market Size by Country (2021-2026)
- 8.2.3 Europe Apatinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Apatinib Sales by Country
- 9.1.1 Asia-Pacific Apatinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Apatinib Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Apatinib Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Apatinib Market Size by Country
- 9.2.1 Asia-Pacific Apatinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Apatinib Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Apatinib Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Apatinib Sales by Country
- 10.1.1 South America Apatinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Apatinib Sales by Country (2021-2026)
- 10.1.3 South America Apatinib Sales Forecast by Country (2027-2032)
- 10.2 South America Apatinib Market Size by Country
- 10.2.1 South America Apatinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Apatinib Market Size by Country (2021-2026)
- 10.2.3 South America Apatinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Apatinib Sales by Country
- 11.1.1 Middle East and Africa Apatinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Apatinib Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Apatinib Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Apatinib Market Size by Country
- 11.2.1 Middle East and Africa Apatinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Apatinib Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Apatinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Apatinib Value Chain Analysis
- 12.1.1 Apatinib Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Apatinib Production Mode & Process
- 12.2 Apatinib Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Apatinib Distributors
- 12.2.3 Apatinib Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst